Pragmatic trial to assess the possibility of enhancing the effectiveness of tinnitus retraining therapy (TRT) by concomitant treatment with Ginkgo biloba extract EGb 761 in patients with chronic tinnitus
Phase of Trial: Phase II
Latest Information Update: 14 Jun 2017
Price : $35 *
At a glance
- Drugs EGb 761 (Primary)
- Indications Tinnitus
- Focus Therapeutic Use
- Sponsors Dr. Willmar Schwabe Pharmaceuticals
- 09 Jun 2017 Status changed from completed to discontinued.
- 01 Jul 2016 Status changed from recruiting to completed.
- 10 Jun 2014 Status changed from not yet recruiting to recruiting, according to ISRCTN: Current Controlled Trials record.